Cargando…

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

We describe the case of a 54-year-old man with nodal recurrence prostate cancer after radical prostatectomy, salvage external-beam radiotherapy and salvage lymph node dissection. The patient was evaluated with a lymphotropic ultrasmall superparamagnetic particles of iron oxide (USPIO)-MRI and a (68)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandini, Marco, Gandaglia, Giorgio, Fossati, Nicola, Montorsi, Francesco, Briganti, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408758/
https://www.ncbi.nlm.nih.gov/pubmed/28462154
http://dx.doi.org/10.1016/j.eucr.2017.02.011
_version_ 1783232358701334528
author Bandini, Marco
Gandaglia, Giorgio
Fossati, Nicola
Montorsi, Francesco
Briganti, Alberto
author_facet Bandini, Marco
Gandaglia, Giorgio
Fossati, Nicola
Montorsi, Francesco
Briganti, Alberto
author_sort Bandini, Marco
collection PubMed
description We describe the case of a 54-year-old man with nodal recurrence prostate cancer after radical prostatectomy, salvage external-beam radiotherapy and salvage lymph node dissection. The patient was evaluated with a lymphotropic ultrasmall superparamagnetic particles of iron oxide (USPIO)-MRI and a (68)Ga radiolabelled prostate specific membrane antigen (Ga68-PSMA) PET-CT scan which enhanced persistent localized nodal disease. The patient was then considered for a second robot-assisted extended S-LND. Differently from preoperative imaging, pathology report revealed a wide nodal involvement mirroring a metastatic disease. The current manuscript is an explanatory case on the limitations of lymph node imaging in prostate cancer recurrence.
format Online
Article
Text
id pubmed-5408758
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54087582017-05-01 An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer Bandini, Marco Gandaglia, Giorgio Fossati, Nicola Montorsi, Francesco Briganti, Alberto Urol Case Rep Oncology We describe the case of a 54-year-old man with nodal recurrence prostate cancer after radical prostatectomy, salvage external-beam radiotherapy and salvage lymph node dissection. The patient was evaluated with a lymphotropic ultrasmall superparamagnetic particles of iron oxide (USPIO)-MRI and a (68)Ga radiolabelled prostate specific membrane antigen (Ga68-PSMA) PET-CT scan which enhanced persistent localized nodal disease. The patient was then considered for a second robot-assisted extended S-LND. Differently from preoperative imaging, pathology report revealed a wide nodal involvement mirroring a metastatic disease. The current manuscript is an explanatory case on the limitations of lymph node imaging in prostate cancer recurrence. Elsevier 2017-03-10 /pmc/articles/PMC5408758/ /pubmed/28462154 http://dx.doi.org/10.1016/j.eucr.2017.02.011 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Bandini, Marco
Gandaglia, Giorgio
Fossati, Nicola
Montorsi, Francesco
Briganti, Alberto
An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
title An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
title_full An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
title_fullStr An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
title_full_unstemmed An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
title_short An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
title_sort explanatory case on the limitations of lymph node staging in recurrent prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408758/
https://www.ncbi.nlm.nih.gov/pubmed/28462154
http://dx.doi.org/10.1016/j.eucr.2017.02.011
work_keys_str_mv AT bandinimarco anexplanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT gandagliagiorgio anexplanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT fossatinicola anexplanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT montorsifrancesco anexplanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT brigantialberto anexplanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT bandinimarco explanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT gandagliagiorgio explanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT fossatinicola explanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT montorsifrancesco explanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer
AT brigantialberto explanatorycaseonthelimitationsoflymphnodestaginginrecurrentprostatecancer